🇺🇸 FDA
Patent

US 9724367

Injectable formulations for organ augmentation

granted A61KA61K35/22A61K45/06

Quick answer

US patent 9724367 (Injectable formulations for organ augmentation) held by RegenMed (Cayman) LTD. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RegenMed (Cayman) LTD.
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K35/22, A61K45/06, A61P, A61P13/12